Production (Stage)
Lexicon Pharmaceuticals, Inc.
LXRX
$0.7667
$0.04976.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 194.84M | 237.96M | 258.37M | 309.96M | 355.60M |
| Total Receivables | 47.45M | 3.47M | 2.90M | 2.62M | 1.53M |
| Inventory | 201.00K | 231.00K | 636.00K | 585.00K | 514.00K |
| Prepaid Expenses | 3.32M | 4.53M | 6.71M | 7.68M | 7.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 245.81M | 246.19M | 268.61M | 320.84M | 364.65M |
|
|
|||||
| Total Current Assets | 245.81M | 246.19M | 268.61M | 320.84M | 364.65M |
| Net Property, Plant & Equipment | 6.95M | 7.32M | 7.15M | 7.14M | 7.20M |
| Long-term Investments | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Goodwill | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 368.00K | 368.00K | 828.00K | 828.00K | 828.00K |
| Total Assets | 297.67M | 298.42M | 321.12M | 373.36M | 417.22M |
|
|
|||||
| Total Accounts Payable | 10.69M | 14.80M | 14.20M | 12.22M | 8.07M |
| Total Accrued Expenses | 11.90M | 29.27M | 20.54M | 14.37M | 14.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 43.10M | 1.18M | 1.30M | 1.29M | 1.29M |
| Total Finance Division Other Current Liabilities | 45.00M | -- | -- | -- | -- |
| Total Other Current Liabilities | 45.00M | -- | -- | -- | -- |
| Total Current Liabilities | 110.69M | 45.25M | 36.05M | 27.88M | 23.40M |
|
|
|||||
| Total Current Liabilities | 110.69M | 45.25M | 36.05M | 27.88M | 23.40M |
| Long-Term Debt | 58.64M | 100.30M | 99.90M | 99.50M | 99.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.52M | 4.60M | 4.68M | 4.89M | 5.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 783.00K | 2.32M | 1.99M | 1.12M | -- |
| Total Liabilities | 174.64M | 152.47M | 142.61M | 133.38M | 128.35M |
|
|
|||||
| Common Stock & APIC | 2.12B | 2.12B | 2.12B | 2.11B | 2.11B |
| Retained Earnings | -1.99B | -1.97B | -1.93B | -1.87B | -1.82B |
| Treasury Stock & Other | -5.16M | -4.50M | -4.27M | -4.81M | -4.67M |
| Total Common Equity | 123.03M | 145.95M | 178.51M | 239.98M | 288.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 23.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 23.00K |
|
|
|||||
| Total Common Equity | 123.03M | 145.95M | 178.51M | 239.98M | 288.84M |
| Total Preferred Equity | -- | -- | -- | -- | 23.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 123.03M | 145.95M | 178.51M | 239.98M | 288.87M |
|
|
|||||